ID   PAPOG_HUMAN             Reviewed;         736 AA.
AC   Q9BWT3; B2RBH4; Q59G05; Q969N1; Q9H8L2; Q9HAD0;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=Poly(A) polymerase gamma;
DE            Short=PAP-gamma;
DE            EC=2.7.7.19;
DE   AltName: Full=Neo-poly(A) polymerase;
DE            Short=Neo-PAP;
DE   AltName: Full=Polynucleotide adenylyltransferase gamma;
DE   AltName: Full=SRP RNA 3'-adenylating enzyme;
DE   AltName: Full=Signal recognition particle RNA-adenylating enzyme;
DE            Short=SRP RNA-adenylating enzyme;
GN   Name=PAPOLG; Synonyms=PAP2, PAPG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE,
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11287430; DOI=10.1074/jbc.M101905200;
RA   Perumal K., Sinha K., Henning D., Reddy R.;
RT   "Purification, characterization, and cloning of the cDNA of human
RT   signal recognition particle RNA 3'-adenylating enzyme.";
RL   J. Biol. Chem. 276:21791-21796(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Melanoma;
RX   PubMed=11463842; DOI=10.1128/MCB.21.16.5614-5623.2001;
RA   Topalian S.L., Kaneko S., Gonzales M.I., Bond G.L., Ward Y.,
RA   Manley J.L.;
RT   "Identification and functional characterization of neo-poly(A)
RT   polymerase, an RNA processing enzyme overexpressed in human tumors.";
RL   Mol. Cell. Biol. 21:5614-5623(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11431479; DOI=10.1074/jbc.M104599200;
RA   Kyriakopoulou C.B., Nordvarg H., Virtanen A.;
RT   "A novel nuclear human poly(A) polymerase (PAP), PAP gamma.";
RL   J. Biol. Chem. 276:33504-33511(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 333-736 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-648; THR-654 AND
RP   SER-684, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-684, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-29; SER-525;
RP   SER-599; SER-684 AND SER-708, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.79 ANGSTROMS) OF 1-508 IN COMPLEX WITH ATP
RP   AND CALCIUM IONS.
RX   PubMed=24076191; DOI=10.1016/j.jmb.2013.09.025;
RA   Yang Q., Nausch L., Martin G., Keller W., Doublie S.;
RT   "Crystal structure of human poly(A) polymerase gamma reveals a
RT   conserved catalytic core for canonical poly(A) polymerases.";
RL   J. Mol. Biol. 426:43-50(2014).
CC   -!- FUNCTION: Responsible for the post-transcriptional adenylation of
CC       the 3'-terminal of mRNA precursors and several small RNAs
CC       including signal recognition particle (SRP) RNA, nuclear 7SK RNA,
CC       U2 small nuclear RNA, and ribosomal 5S RNA.
CC       {ECO:0000269|PubMed:11287430, ECO:0000269|PubMed:11463842}.
CC   -!- CATALYTIC ACTIVITY: ATP + RNA(n) = diphosphate + RNA(n+1).
CC       {ECO:0000269|PubMed:11287430, ECO:0000269|PubMed:11431479,
CC       ECO:0000269|PubMed:11463842}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Binds 2 magnesium ions. Also active with manganese.
CC       {ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.051 uM for poly(A)(15) {ECO:0000269|PubMed:11431479};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11287430,
CC       ECO:0000269|PubMed:11431479, ECO:0000269|PubMed:11463842}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BWT3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BWT3-2; Sequence=VSP_054379;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in testis, and weakly
CC       in other tissues. Overexpressed in several tumors.
CC       {ECO:0000269|PubMed:11463842}.
CC   -!- SIMILARITY: Belongs to the poly(A) polymerase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14604.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY029162; AAK31791.1; -; mRNA.
DR   EMBL; AF312211; AAK83701.1; -; mRNA.
DR   EMBL; AJ308101; CAC59751.1; -; mRNA.
DR   EMBL; AK021867; BAB13919.1; -; mRNA.
DR   EMBL; AK023544; BAB14604.1; ALT_INIT; mRNA.
DR   EMBL; AK314663; BAG37221.1; -; mRNA.
DR   EMBL; AC011245; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAX00034.1; -; Genomic_DNA.
DR   EMBL; BC111701; AAI11702.1; -; mRNA.
DR   EMBL; BC113747; AAI13748.1; -; mRNA.
DR   EMBL; AB209304; BAD92541.1; -; mRNA.
DR   CCDS; CCDS1863.1; -. [Q9BWT3-1]
DR   RefSeq; NP_075045.2; NM_022894.3. [Q9BWT3-1]
DR   RefSeq; XP_005264557.1; XM_005264500.3. [Q9BWT3-2]
DR   UniGene; Hs.387471; -.
DR   PDB; 4LT6; X-ray; 2.79 A; A/B=1-508.
DR   PDBsum; 4LT6; -.
DR   ProteinModelPortal; Q9BWT3; -.
DR   SMR; Q9BWT3; -.
DR   BioGrid; 122338; 9.
DR   IntAct; Q9BWT3; 2.
DR   STRING; 9606.ENSP00000238714; -.
DR   iPTMnet; Q9BWT3; -.
DR   PhosphoSitePlus; Q9BWT3; -.
DR   BioMuta; PAPOLG; -.
DR   DMDM; 116242699; -.
DR   EPD; Q9BWT3; -.
DR   MaxQB; Q9BWT3; -.
DR   PaxDb; Q9BWT3; -.
DR   PeptideAtlas; Q9BWT3; -.
DR   PRIDE; Q9BWT3; -.
DR   Ensembl; ENST00000238714; ENSP00000238714; ENSG00000115421. [Q9BWT3-1]
DR   GeneID; 64895; -.
DR   KEGG; hsa:64895; -.
DR   UCSC; uc002sai.4; human. [Q9BWT3-1]
DR   CTD; 64895; -.
DR   DisGeNET; 64895; -.
DR   GeneCards; PAPOLG; -.
DR   HGNC; HGNC:14982; PAPOLG.
DR   HPA; CAB017795; -.
DR   HPA; HPA035349; -.
DR   HPA; HPA035350; -.
DR   MIM; 616865; gene.
DR   neXtProt; NX_Q9BWT3; -.
DR   OpenTargets; ENSG00000115421; -.
DR   PharmGKB; PA32934; -.
DR   eggNOG; KOG2245; Eukaryota.
DR   eggNOG; COG5186; LUCA.
DR   GeneTree; ENSGT00390000017928; -.
DR   HOGENOM; HOG000204376; -.
DR   HOVERGEN; HBG053502; -.
DR   InParanoid; Q9BWT3; -.
DR   KO; K14376; -.
DR   OMA; MLDSQRQ; -.
DR   OrthoDB; EOG091G0571; -.
DR   PhylomeDB; Q9BWT3; -.
DR   TreeFam; TF300842; -.
DR   GeneWiki; PAPOLG; -.
DR   GenomeRNAi; 64895; -.
DR   PRO; PR:Q9BWT3; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115421; -.
DR   CleanEx; HS_PAPOLG; -.
DR   ExpressionAtlas; Q9BWT3; baseline and differential.
DR   Genevisible; Q9BWT3; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IDA:UniProtKB.
DR   GO; GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006378; P:mRNA polyadenylation; IBA:GO_Central.
DR   GO; GO:0043631; P:RNA polyadenylation; IDA:UniProtKB.
DR   InterPro; IPR011068; NuclTrfase_I_C.
DR   InterPro; IPR007012; PolA_pol_cen_dom.
DR   InterPro; IPR007010; PolA_pol_RNA-bd_dom.
DR   InterPro; IPR014492; PolyA_polymerase.
DR   InterPro; IPR002934; Polymerase_NTP_transf_dom.
DR   PANTHER; PTHR10682; PTHR10682; 1.
DR   Pfam; PF01909; NTP_transf_2; 1.
DR   Pfam; PF04928; PAP_central; 1.
DR   Pfam; PF04926; PAP_RNA-bind; 2.
DR   SUPFAM; SSF55003; SSF55003; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Direct protein sequencing; Magnesium; Manganese;
KW   Metal-binding; mRNA processing; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; RNA-binding; Transferase.
FT   CHAIN         1    736       Poly(A) polymerase gamma.
FT                                /FTId=PRO_0000051624.
FT   NP_BIND      99    101       ATP. {ECO:0000269|PubMed:24076191}.
FT   NP_BIND     112    114       ATP. {ECO:0000269|PubMed:24076191}.
FT   NP_BIND     245    246       ATP. {ECO:0000269|PubMed:24076191}.
FT   METAL       112    112       Magnesium 1; catalytic.
FT   METAL       112    112       Magnesium 2; catalytic. {ECO:0000250}.
FT   METAL       114    114       Magnesium 1; catalytic.
FT   METAL       114    114       Magnesium 2; catalytic. {ECO:0000250}.
FT   METAL       166    166       Magnesium 2; catalytic. {ECO:0000250}.
FT   BINDING     108    108       ATP. {ECO:0000250}.
FT   BINDING     166    166       ATP. {ECO:0000250}.
FT   BINDING     227    227       ATP. {ECO:0000269|PubMed:24076191}.
FT   BINDING     236    236       ATP. {ECO:0000269|PubMed:24076191}.
FT   SITE        152    152       Interaction with RNA. {ECO:0000250}.
FT   SITE        157    157       Interaction with RNA. {ECO:0000250}.
FT   SITE        327    327       Interaction with RNA. {ECO:0000250}.
FT   SITE        398    398       Interaction with RNA. {ECO:0000250}.
FT   SITE        532    532       Interaction with RNA. {ECO:0000250}.
FT   MOD_RES       2      2       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES      23     23       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     525    525       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     599    599       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     654    654       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     684    684       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     708    708       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     664    685       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.8}.
FT                                /FTId=VSP_054379.
FT   CONFLICT     31     31       K -> E (in Ref. 1; AAK31791).
FT                                {ECO:0000305}.
FT   CONFLICT    289    289       P -> S (in Ref. 1; AAK31791).
FT                                {ECO:0000305}.
FT   CONFLICT    619    619       T -> I (in Ref. 1; AAK31791).
FT                                {ECO:0000305}.
FT   STRAND       19     22       {ECO:0000244|PDB:4LT6}.
FT   HELIX        32     45       {ECO:0000244|PDB:4LT6}.
FT   HELIX        46     48       {ECO:0000244|PDB:4LT6}.
FT   HELIX        54     78       {ECO:0000244|PDB:4LT6}.
FT   TURN         79     83       {ECO:0000244|PDB:4LT6}.
FT   HELIX        86     89       {ECO:0000244|PDB:4LT6}.
FT   STRAND       95     99       {ECO:0000244|PDB:4LT6}.
FT   HELIX       100    104       {ECO:0000244|PDB:4LT6}.
FT   STRAND      113    119       {ECO:0000244|PDB:4LT6}.
FT   HELIX       125    138       {ECO:0000244|PDB:4LT6}.
FT   STRAND      142    148       {ECO:0000244|PDB:4LT6}.
FT   STRAND      150    153       {ECO:0000244|PDB:4LT6}.
FT   STRAND      155    160       {ECO:0000244|PDB:4LT6}.
FT   STRAND      163    171       {ECO:0000244|PDB:4LT6}.
FT   STRAND      173    175       {ECO:0000244|PDB:4LT6}.
FT   HELIX       186    189       {ECO:0000244|PDB:4LT6}.
FT   HELIX       194    211       {ECO:0000244|PDB:4LT6}.
FT   HELIX       216    232       {ECO:0000244|PDB:4LT6}.
FT   TURN        238    241       {ECO:0000244|PDB:4LT6}.
FT   HELIX       245    258       {ECO:0000244|PDB:4LT6}.
FT   HELIX       264    277       {ECO:0000244|PDB:4LT6}.
FT   TURN        301    303       {ECO:0000244|PDB:4LT6}.
FT   HELIX       307    309       {ECO:0000244|PDB:4LT6}.
FT   STRAND      318    320       {ECO:0000244|PDB:4LT6}.
FT   HELIX       330    350       {ECO:0000244|PDB:4LT6}.
FT   TURN        351    353       {ECO:0000244|PDB:4LT6}.
FT   HELIX       357    361       {ECO:0000244|PDB:4LT6}.
FT   TURN        366    368       {ECO:0000244|PDB:4LT6}.
FT   STRAND      371    382       {ECO:0000244|PDB:4LT6}.
FT   HELIX       383    394       {ECO:0000244|PDB:4LT6}.
FT   HELIX       397    406       {ECO:0000244|PDB:4LT6}.
FT   STRAND      410    420       {ECO:0000244|PDB:4LT6}.
FT   STRAND      432    442       {ECO:0000244|PDB:4LT6}.
FT   HELIX       456    472       {ECO:0000244|PDB:4LT6}.
FT   STRAND      481    489       {ECO:0000244|PDB:4LT6}.
FT   HELIX       492    494       {ECO:0000244|PDB:4LT6}.
SQ   SEQUENCE   736 AA;  82803 MW;  B0F6F217AA36E552 CRC64;
     MKEMSANTVL DSQRQQKHYG ITSPISLASP KEIDHIYTQK LIDAMKPFGV FEDEEELNHR
     LVVLGKLNNL VKEWISDVSE SKNLPPSVVA TVGGKIFTFG SYRLGVHTKG ADIDALCVAP
     RHVERSDFFQ SFFEKLKHQD GIRNLRAVED AFVPVIKFEF DGIEIDLVFA RLAIQTISDN
     LDLRDDSRLR SLDIRCIRSL NGCRVTDEIL HLVPNKETFR LTLRAVKLWA KRRGIYSNML
     GFLGGVSWAM LVARTCQLYP NAAASTLVHK FFLVFSKWEW PNPVLLKQPE ESNLNLPVWD
     PRVNPSDRYH LMPIITPAYP QQNSTYNVST STRTVMVEEF KQGLAVTDEI LQGKSDWSKL
     LEPPNFFQKY RHYIVLTASA STEENHLEWV GLVESKIRVL VGNLERNEFI TLAHVNPQSF
     PGNKEHHKDN NYVSMWFLGI IFRRVENAES VNIDLTYDIQ SFTDTVYRQA NNINMLKEGM
     KIEATHVKKK QLHHYLPAEI LQKKKKQSLS DVNRSSGGLQ SKRLSLDSSC LDSSRDTDNG
     TPFNSPASKS DSPSVGETER NSAEPAAVIV EKPLSVPPAQ GLSIPVIGAK VDSTVKTVSP
     PTVCTIPTVV GRNVIPRITT PHNPAQGQPH LNGMSNITKT VTPKRSHSPS IDGTPKRLKD
     VEKFIRLEST FKDPRTAEER KRKSVDAIGG ESMPIPTIDT SRKKRLPSKE LPDSSSPVPA
     NNIRVIKNSI RLTLNR
//
